| Gene symbol | PKN3 | Synonyms | UTDP4-1 | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9q34.11 | dbXrefs | |
| Description | protein kinase N3 | ||||
| GTO ID | GTC0087 |
| Trial ID | NCT00938574 |
| Disease | Advanced Solid Tumor |
| Altered gene | PKN3 |
| Therapeutic/Target gene | Target gene |
| Therapy | siRNA |
| Treatment | Atu027 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Prospective, Open-label, Single Center, Dose Finding Phase I-study With Atu027 (an siRNA Formulation) in Subjects With Advanced Solid Cancer |
| Year | 2009 |
| Country | Germany |
| Company sponsor | Silence Therapeutics GmbH |
| Other ID(s) | Atu027-I-01|EudraCT-No: 2008-005588-32 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||